ISA PHARMACEUTICALS B V has a total of 35 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TARVEDA THERAPEUTICS INC, SQUAREX LLC and VEDANTRA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Australia | 2 | |
#7 | China | 2 | |
#8 | Israel | 2 | |
#9 | Mexico | 2 | |
#10 | Singapore | 2 | |
#11 | Brazil | 1 | |
#12 | EAPO (Eurasian Patent Organization) | 1 | |
#13 | India | 1 | |
#14 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ossendorp Ferdinand Antonius | 10 |
#2 | Melief Cornelis Johannes Maria | 10 |
#3 | Mulder Gwenn Eveline | 10 |
#4 | Filippov Dmitri Viktorovitsj | 10 |
#5 | Khan Selina | 10 |
#6 | Van Der Marel Gijsbert Arie | 9 |
#7 | Krebber Wilhelmus Johannes Theodorus Alexander | 9 |
#8 | Melief Cornelis Joseph Maria | 8 |
#9 | Kessler Johan Herman | 7 |
#10 | Kwappenberg Kitty Michelle Corinne | 7 |
Publication | Filing date | Title |
---|---|---|
WO2019122050A1 | Methods of immunization | |
CN109641039A | Peptide vaccine preparation | |
KR20170008873A | Synthetic long peptides (slp) for therapeutic vaccination against hepatitis b virus infection | |
KR20140093673A | Adjuvant compound | |
EP2687849A1 | A process for providing an optimized immune therapy composition | |
WO2013006050A1 | Peptides inducing or enhancing an immune response against prostate-specific membrane protein (psma) |